
10 March @ 10:00 am – 11:00 am Online
Europe’s biotech sector continues to face significant financing challenges, especially during growth and scale‑up. As the EU moves forward with the landmark Biotech Act, this webinar explores the funding tools available today, how companies can access them, and what changes are needed to expand investment in European biotech.
The session will provide an overview of current EU public and blended finance options across the development pipeline, explain how the European Investment Bank evaluates and supports biotech projects, and offer first-hand insights from a biotech founder on securing funding from idea to market. It will also examine how upcoming EU initiatives could improve access to capital and attract more private investment.
Speakers include
Felicitas Riedl, Director of Innovation and Competitiveness at the European Investment Bank
Raffael Wohlgensinger, Founder & CEO, Formo
Jessica Martinsson, our moderator and CEO of SwedenBIO, the Swedish Biotech Association
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.